Print outs are available to registered users. Please log in or register.
Summary of pneumococcal immunisation policy
Public Health England
Pneumococcal vaccine is recommended for:
infants as part of the routine childhood immunisation programme
all those aged 65 years and over
all those aged 2 months and over in the clinical risk groups as set out in the table
Previously unvaccinated children and adults requiring splenectomy or commencing immunosuppressive treatment may be at an increased risk of pneumococcal disease and should be vaccinated according to the schedule for this specific risk group
There are two types of pneumococcal vaccine—23-valent pneumococcal polysaccharide vaccine (PPV) and 13-valent pneumococcal conjugate vaccine (PCV)
Primary care staff should identify patients for whom vaccine is recommended and use all opportunities to ensure that they are appropriately immunised, for example:
when immunising against influenza
at other routine consultations, especially on discharge after hospital admission
Most healthy adults develop a good antibody response to a single dose of polysaccharide vaccine by the third week following immunisation
Management of asthma in adults over 65 years of age
Development group: Gruffydd-Jones, McArthur, Murphy, Russell & Wise. This management algorithm was developed by a multidisciplinary expert panel: Gruffydd-Jones K et al with the support of a grant from Teva UK Limited.